HAIM
CVS icon

Hunter Associates Investment Management’s CVS Health CVS Stock Holding History

Hunter Associates Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,746
Closed -$1.81M – 261
2023
Q4 		$1.81M Sell
22,746
-360
-2% -$25.6K 0.33% 74
2023
Q3 		$1.59M Sell
23,106
-8,973
-28% -$636K 0.32% 69
2023
Q2 		$2.21M Sell
32,079
-9,934
-24% -$707K 0.43% 59
2023
Q1 		$3.12M Buy
42,013
+6,697
+19% +$562K 0.67% 40
2022
Q4 		$3.29M Sell
35,316
-2,883
-8% -$278K 0.79% 33
2022
Q3 		$3.65M Sell
38,199
-260
-0.7% -$25.7K 0.95% 29
2022
Q2 		$3.57M Buy
38,459
+26,459
+220% +$2.58M 0.88% 30
2022
Q1 		$1.22M Buy
12,000
+2,000
+20% +$210K 0.39% 54
2021
Q4 		$1.03M Buy
10,000
+2,000
+25% +$185K 0.3% 62
2021
Q3 		$679K Hold
8,000
– – 0.22% 76
2021
Q2 		$668K Sell
8,000
-32,539
-80% -$2.66M 0.21% 77
2021
Q1 		$3.05M Sell
40,539
-1,163
-3% -$84.7K 0.71% 38
2020
Q4 		$2.85M Sell
41,702
-592
-1% -$38.5K 0.7% 38
2020
Q3 		$2.47M Buy
42,294
+600
+1% +$37.3K 0.69% 35
2020
Q2 		$2.71M Buy
41,694
+23,031
+123% +$1.45M 0.81% 33
2020
Q1 		$1.11M Buy
18,663
+7,475
+67% +$499K 0.43% 56
2019
Q4 		$831K Buy
+11,188
New +$786K 0.26% 76
2018
Q4 		– Sell
-2,780
Closed -$219K – 154
2018
Q3 		$219K Sell
2,780
-1,601
-37% -$114K 0.08% 153
2018
Q2 		$282K Buy
4,381
+250
+6% +$16.5K 0.1% 131
2018
Q1 		$257K Hold
4,131
– – 0.1% 141
2017
Q4 		$299K Buy
4,131
+226
+6% +$16.4K 0.11% 129
2017
Q3 		$318K Hold
3,905
– – 0.12% 123
2017
Q2 		$314K Buy
3,905
+100
+3% +$7.9K 0.13% 124
2017
Q1 		$299K Buy
3,805
+125
+3% +$9.98K 0.13% 129
2016
Q4 		$290K Buy
3,680
+250
+7% +$20.2K 0.12% 129
2016
Q3 		$305K Sell
3,430
-106
-3% -$10K 0.13% 123
2016
Q2 		$339K Buy
+3,536
New +$352K 0.15% 113

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hunter Associates Investment Management's CVS Position: Q1 2024 in Review

Hunter Associates Investment Management sold out of CVS Health (CVS) in Q1 2024, closing a stake of 22,746 shares — an estimated $1.81M sold.

Hunter Associates Investment Management first reported a position in CVS in Q2 2016 and held it in 27 quarters. The position peaked at $3.65M in Q3 2022. 2,177 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Hunter Associates Investment Management reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Hunter Associates Investment Management sold 22,746 CVS Health shares in Q1 2024, an estimated $1.81M.
  • Hunter Associates Investment Management first reported a position in CVS Health in Q2 2016 and held it in 27 quarters.
  • Hunter Associates Investment Management's CVS Health position peaked at $3.65M in Q3 2022.
  • 2,177 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Hunter Associates Investment Management's 13F filing for Q1 2024, filed 1 May 2024.